BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 29947108)

  • 1. Diagnostic Value of
    Lao TD; Truong PK; Le TAH
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis.
    Li Y; Liu C; Xin L; Liu C; Cao J; Yue Z; Sheng J; Yuan Y; Zhou Q; Liu Z
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):62-70. PubMed ID: 38143381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma.
    Goulioumis A; Gyftopoulos K
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W
    Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model.
    Duan J; Yang Y; Wu Z; Lin S; Zhou C; Sheng G; Yang F; Bian L; Zhang X; Xiao S
    Cancer Manag Res; 2019; 11():7377-7389. PubMed ID: 31496799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer.
    Peng J; Qi S; Wang P; Li W; Song L; Liu C; Li F
    Future Oncol; 2016 Mar; 12(5):715-26. PubMed ID: 26653706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
    Li Z; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells].
    Li Z; Lin SX; Liang YJ
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):238-42. PubMed ID: 12839684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-8 suppresses E-cadherin expression in nasopharyngeal carcinoma cells by enhancing E-cadherin promoter DNA methylation.
    Zhang RL; Peng LX; Yang JP; Zheng LS; Xie P; Wang MY; Huang BJ; Zhao HR; Bao YX; Qian CN
    Int J Oncol; 2016 Jan; 48(1):207-14. PubMed ID: 26530812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis.
    Wu C; Peng S; Sun W; Luo M; Su B; Liu D; Hu G
    Head Neck; 2018 Nov; 40(11):2538-2545. PubMed ID: 29947108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
    Ye M; Huang T; Ni C; Yang P; Chen S
    EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.